Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Genu Neurexa Orthosis in Post Stroke Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients suffering a first stro(at least 3 months post stroke)~* Cognitive and cooperative ability to follo instructions.~* Patients suffering from paresis of leg muscles resulting in knee hyperextension.~* Ability to walk with or without a walking aid (cane, walker) independently~Exclusion Criteria:~* Cognitive disorders preventing the subject from understanding the trial protocol, signing a consent form or following the researcher's instructions~* Skin disease or wounds at the paretic knee~* Ankle or foot contructure or limited range of motion~* Orthopaedic injury to the paretic or non-paretic limbs

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).